HIV-1 p17 antibody (full length)
Quick Overview for HIV-1 p17 antibody (full length) (ABIN2452017)
Target
Reactivity
Host
Clonality
Conjugate
Application
-
-
Binding Specificity
- full length
-
Characteristics
- Whole Antiserum
-
Purification
- Guinea Pig serum
-
Immunogen
- Purified full-size recombinant Gag p17 of HIV-1 subtype B expressed in E. coli
-
-
-
-
Application Notes
-
1. Western blot
2. Dot blot
3. Immunoprecipitation
4. ELISA
Other applications have not been tested -
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Buffer
- 0.09 % sodium azide
-
Preservative
- Sodium azide
-
Precaution of Use
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Storage
- -20 °C
-
Storage Comment
- Upon receipt aliquot and store at -20 C
-
-
-
: "HIV-1 gag proteins: diverse functions in the virus life cycle." in: Virology, Vol. 251, Issue 1, pp. 1-15, (1998) (PubMed).
: "Overproduction, purification, and diagnostic use of the recombinant HIV-1 Gag proteins, the precursor protein p55 and the processed products p17, p24, and p15." in: Microbiology and immunology, Vol. 39, Issue 7, pp. 473-83, (1996) (PubMed).
: "Production of acquired immunodeficiency syndrome-associated retrovirus in human and nonhuman cells transfected with an infectious molecular clone." in: Journal of virology, Vol. 59, Issue 2, pp. 284-91, (1986) (PubMed).
-
-
- HIV-1 p17 (Human Immunodeficiency Virus 1 Matrix (HIV-1 p17))
-
Alternative Name
- HIV-1 Gag p17
-
Target Type
- Viral Protein
-
Background
- HIV-1 Gag p17 is the matrix protein of AIDS virus HIV-1 and is processed by digestion of its precursor Gag p55 by HIV-1 protease. This protein is indispensable to the reproduction of AIDS virus and constitute the essential element of the of AIDS virus particle construction.
Target
-